APR 24, 2020 1:44 AM PDT

Drug Targets Hard To Treat Uterine Cancer

WRITTEN BY: Nouran Amin

A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The drug caused DNA damage inside tumors resulting in shrinkage for about one-third of patients.

“The preliminary results, to be presented online at Thursday's virtual session of the Society for Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer, demonstrated strong activity of WEE1-directed therapy in uterine serous carcinoma (USC), which accounts for about 10% of uterine cancers but up to 40% of deaths from the disease” trial leaders say.

The drug is called ‘adavosertib’ and works by stopping DNA from replicating in the tumor cells. Specifically, it targets a protein called WEE1 that is involved in the replication process. Some side-effects of the drug include anemia, diarrhea, nausea, and fatigue.

Learn more about uterine cancer (also known as endometrial cancer):

"Adavosertib demonstrated remarkable activity as a single agent in this group of patients," says the study's lead author, Joyce Liu, MD, MPH, of Dana-Farber. "It's especially encouraging in a disease such as USC, for which current treatments are of limited effectiveness."

The study involved 35 participants all of whom who underwent platinum-based chemotherapy.

“In some cases, the responses were exceptionally durable, with some patients still responding more than a year after undergoing treatment,” study leaders say.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
DEC 02, 2020
Immunology
A Shingles Vaccine for Cancer Patients
DEC 02, 2020
A Shingles Vaccine for Cancer Patients
Receiving a vaccine (usually in the form of an inactivated pathogen) triggers an immune response without the symptoms of ...
DEC 18, 2020
Drug Discovery & Development
Lab-Induced Hallucinations Could Help Develop New Drugs
DEC 18, 2020
Lab-Induced Hallucinations Could Help Develop New Drugs
Researchers from the University of New South Wales in Australia have found that inducing hallucinations in healthy subje ...
DEC 04, 2020
Drug Discovery & Development
OTC Drug Found Safe for Multiple Myeloma
DEC 04, 2020
OTC Drug Found Safe for Multiple Myeloma
Injecting the immune-boosting drug ‘teclistamab’ was found to be safe and effective in patients with relapse ...
DEC 22, 2020
Technology
New RNA Discovery Tool Accelerates Drug Discovery
DEC 22, 2020
New RNA Discovery Tool Accelerates Drug Discovery
Some diseases, such as metastatic breast cancer are known as “undruggable” or best described as unresponsive ...
JAN 01, 2021
Microbiology
A New Type of Antibiotics Help the Immune System Fight Pathogens
JAN 01, 2021
A New Type of Antibiotics Help the Immune System Fight Pathogens
Reporting in Nature, scientists have identified a new group of compounds that may help us get out of the antibiotic-resi ...
Loading Comments...